Literature DB >> 18633582

[Therapy of cardiogenic shock after myocardial infarction].

M Ferrari1, H R Figulla.   

Abstract

The therapy of infarct related cardiogenic shock should primarily focus on fastest possible revascularization. In addition, rapid restoration of sufficient organ perfusion pressure is recommended for the prevention of a multi-organ dysfunction syndrome (MODS). This can be achieved by mechanical circulatory assist devices as well as individual catecholamine therapy. Since assist devices require specially trained physicians, their use is limited to specialized cardiac care centers. However, future technologies such as portable heart-lung-machines may help to further improve transfer to specialized centers and therapy of shock patients.

Entities:  

Mesh:

Year:  2008        PMID: 18633582     DOI: 10.1007/s00108-008-2076-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Thrombolysis in Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  LIFEBRIDGE: a portable, modular, rapidly available "plug-and-play" mechanical circulatory support system.

Authors:  Uwe Mehlhorn; Michael Brieske; Uwe M Fischer; Markus Ferrari; Patrick Brass; Juergen H Fischer; Hans-R Zerkowski
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

4.  Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.

Authors:  Harvey D White; Susan F Assmann; Timothy A Sanborn; Alice K Jacobs; John G Webb; Lynn A Sleeper; Cheuk-Kit Wong; James T Stewart; Philip E G Aylward; Shing-Chiu Wong; Judith S Hochman
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

Review 5.  Cardiogenic shock.

Authors:  S M Hollenberg; C J Kavinsky; J E Parrillo
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

6.  Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.

Authors:  John H Alexander; Harmony R Reynolds; Amanda L Stebbins; Vladimir Dzavik; Robert A Harrington; Frans Van de Werf; Judith S Hochman
Journal:  JAMA       Date:  2007-03-26       Impact factor: 56.272

7.  Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Authors:  R D Anderson; E M Ohman; D R Holmes; I Col; A L Stebbins; E R Bates; R J Stomel; C B Granger; E J Topol; R M Califf
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

8.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

Authors:  Markku S Nieminen; Dirk Brutsaert; Kenneth Dickstein; Helmut Drexler; Ferenc Follath; Veli-Pekka Harjola; Matthias Hochadel; Michel Komajda; Johan Lassus; Jose Luis Lopez-Sendon; Piotr Ponikowski; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

9.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  1 in total

1.  ["Bridge to recovery"- implantation of an Impella® CP in infarct-related cardiogenic shock].

Authors:  G Fröhlich; A Pibernik; M Ferrari
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-11-05       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.